Literature DB >> 19319929

The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease.

Deidre J Devier1, Gregory H Pelton, Matthias H Tabert, Xinhua Liu, Katrina Cuasay, Rachel Eisenstadt, Karen Marder, Yaakov Stern, D P Devanand.   

Abstract

OBJECTIVE: To compare state and trait anxiety in mild cognitive impairment (MCI) patients and matched control subjects, and to assess the impact of these variables in predicting conversion to Alzheimer's disease.
METHODS: One hundred and forty-eight patients with MCI, broadly defined, were assessed and followed systematically. Baseline predictors for follow-up conversion to AD (entire sample: 39/148 converted to Alzheimer's disease (AD)) included the Spielberger State-Trait Anxiety Inventory (STAI).
RESULTS: At baseline evaluation, MCI patients had higher levels of state and trait anxiety than controls, with no differences between future AD converters (n = 39) and non-converters. In age-stratified Cox proportional hazards model analyses, STAI State was not a significant predictor of conversion to AD (STAI State < or =30 vs. > 30 risk ratio, 1.68; 95% CI, 0.75, 3.77; p = 0.21), but higher Trait scores indicated a lower risk of conversion when STAI State, education, the Folstein Mini-Mental State Examination and HAM-D (depression score) were also included in the model (STAI Trait < or =30 vs. > 30 risk ratio, 0.36; 95% CI, 0.16, 0.82; p = 0.015).
CONCLUSIONS: In contrast to two other recent studies that showed anxiety predicted cognitive decline or conversion to AD, in this clinic-based sample, state anxiety was not a significant predictor. However, higher Trait anxiety predicted a lower risk of future conversion to AD. Further research with systematic long-term follow-up in larger samples is needed to clarify the role of state and trait anxiety in predicting MCI conversion to AD. Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19319929      PMCID: PMC2787890          DOI: 10.1002/gps.2263

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  32 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

3.  Depressive symptomatology and incident cognitive decline in an elderly community sample.

Authors:  S S Bassuk; L F Berkman; D Wypij
Journal:  Arch Gen Psychiatry       Date:  1998-12

4.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

Review 5.  Panic and phobic anxiety: defining phenotypes for genetic studies.

Authors:  J W Smoller; M T Tsuang
Journal:  Am J Psychiatry       Date:  1998-09       Impact factor: 18.112

Review 6.  Is MCI really just early dementia? A systematic review of conversion studies.

Authors:  Maddalena Bruscoli; Simon Lovestone
Journal:  Int Psychogeriatr       Date:  2004-06       Impact factor: 3.878

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

Authors:  D P Devanand; M Sano; M X Tang; S Taylor; B J Gurland; D Wilder; Y Stern; R Mayeux
Journal:  Arch Gen Psychiatry       Date:  1996-02

9.  Measurement and prediction of functional capacity in Alzheimer's disease.

Authors:  Y Stern; D Hesdorffer; M Sano; R Mayeux
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

10.  On the nature and pattern of neurocognitive function in major depressive disorder.

Authors:  K K Zakzanis; L Leach; E Kaplan
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  1998-07
View more
  14 in total

1.  Vulnerability to stress, anxiety, and development of dementia in old age.

Authors:  Robert S Wilson; Christopher T Begeny; Patricia A Boyle; Julie A Schneider; David A Bennett
Journal:  Am J Geriatr Psychiatry       Date:  2011-04       Impact factor: 4.105

Review 2.  Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).

Authors:  Ingrid Arevalo-Rodriguez; Nadja Smailagic; Marta Roqué I Figuls; Agustín Ciapponi; Erick Sanchez-Perez; Antri Giannakou; Olga L Pedraza; Xavier Bonfill Cosp; Sarah Cullum
Journal:  Cochrane Database Syst Rev       Date:  2015-03-05

3.  Sleep quality and 1-year incident cognitive impairment in community-dwelling older adults.

Authors:  Olivier Potvin; Dominique Lorrain; Hélène Forget; Micheline Dubé; Sébastien Grenier; Michel Préville; Carol Hudon
Journal:  Sleep       Date:  2012-04-01       Impact factor: 5.849

4.  Moderating risk of Alzheimer's disease through the use of anxiolytic agents.

Authors:  Shanna L Burke; Janice O'Driscoll; Amary Alcide; Tan Li
Journal:  Int J Geriatr Psychiatry       Date:  2016-11-02       Impact factor: 3.485

5.  Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.

Authors:  Linda Mah; Malcolm A Binns; David C Steffens
Journal:  Am J Geriatr Psychiatry       Date:  2014-10-29       Impact factor: 4.105

6.  Longitudinal Changes in Anger, Anxiety, and Fatigue Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease.

Authors:  Ganesh M Babulal; Ling Chen; Jason M Doherty; Samantha A Murphy; Ann M Johnson; Catherine M Roe
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

7.  Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment.

Authors:  I H G B Ramakers; F R J Verhey; P Scheltens; H Hampel; H Soininen; P Aalten; M Olde Rikkert; M M Verbeek; L Spiru; K Blennow; J Q Trojanowski; L M Shaw; P J Visser
Journal:  Psychol Med       Date:  2012-09-07       Impact factor: 7.723

Review 8.  Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease.

Authors:  Edward C Lauterbach
Journal:  Am J Neurodegener Dis       Date:  2016-03-01

9.  The Alzheimer's disease cooperative study prevention instrument project: longitudinal outcome of behavioral measures as predictors of cognitive decline.

Authors:  Sarah Jane Banks; Rema Raman; Feng He; David P Salmon; Steven Ferris; Paul Aisen; Jeffrey Cummings
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-12-18

10.  Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI).

Authors:  Ingrid Arevalo-Rodriguez; Nadja Smailagic; Marta Roqué-Figuls; Agustín Ciapponi; Erick Sanchez-Perez; Antri Giannakou; Olga L Pedraza; Xavier Bonfill Cosp; Sarah Cullum
Journal:  Cochrane Database Syst Rev       Date:  2021-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.